NURIX THERAPEUTICS INC (NRIX) Stock Cash Flow
NASDAQ:NRIX - Nasdaq - US67080M1036 - Common Stock - Currency: USD
| 2024 (2024-11-30) | 2023 (2023-11-30) | 2022 (2022-11-30) | 2021 (2021-11-30) | 2020 (2020-11-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -193.57M | -143.95M | -180.36M | -117.19M | -43.24M | |||
| Depreciation Amortization | 16.43M | 13.65M | 5.35M | 2.79M | 2.18M | |||
| Change In Working Capital | -18.40M | 20.12M | -19.02M | 9.11M | 36.41M | |||
| Taxes Paid | N/A | N/A | 0.00 | 480.00K | 0.00 | |||
| Other non cash items | 22.96M | 28.81M | 34.23M | 20.93M | 4.57M | |||
| OPERATING CASH FLOW | -172.58M | -81.36M | -159.81M | -84.37M | -80.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.27M | -8.40M | -12.24M | -5.66M | -4.55M | |||
| Other Investing Activity | -248.44M | 76.70M | 39.44M | -102.59M | -249.85M | |||
| INVESTING CASH FLOW | -257.71M | 68.30M | 27.20M | -108.25M | -254.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 485.67M | 3.22M | 117.19M | 153.88M | 339.02M | |||
| FINANCING CASH FLOW | 485.67M | 3.22M | 117.19M | 153.88M | 339.02M | |||
| CHANGE IN CASH | 55.37M | -9.85M | -15.42M | -38.74M | 84.54M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -172.58M | -81.36M | -159.81M | -84.37M | -80.00K | |||
| Capital Expenditure | -9.27M | -8.40M | -12.24M | -5.66M | -4.55M | |||
| FREE CASH FLOW | -181.86M | -89.77M | -172.05M | -90.03M | -4.63M | |||
All data in USD